Clinical Trial Update: Botswana Study of UC-781 Vaginal Microbicide [Phase 1]

View source ↗

Summary

A Phase 1 Botswana trial evaluating the UC-781 vaginal microbicide for HIV prevention has been withdrawn. The sponsor is the Centers for Disease Control and Pre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• UC-781

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: HIV Infections | Phase 1 | Status: WITHDRAWN